tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

FTNTFortinet

Technology · Computer Peripherals · Nasdaq
Compare with peers → Embed
Planned sales, announced before they happen

6 trading plans running, 23 Form 144 notices for $158.3M

10-Q, 10-K and Form 144
Plans running now
6
Janet Napolitano, Christiane Ohlgart, John Whittle, Michael Xie, Ken Xie
Plans adoptedList ↓
19
reported since May 8, 2023
Form 144 noticesList ↓
23
$158.3M the sellers expected to sell

What FTNT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans

Plans adopted or ended

XBRL, 10-Q and 10-K
InsiderWhatDateSharesRuns toReported in
Janet Napolitano
Adopted 10b5-1 plan Aug 31, 2026 up to 390 Dec 3, 2027 10-Q Oct 30, 2026
What the company wrote
On August 31, 2026, Janet Napolitano, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Napolitano Plan”) during an open trading window in accordance with our insider trading policy. The Napolitano Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Napolitano Plan provides for the potential sale by Ms. Napolitano of up to 390 shares of our common stock, plus up to 60% of the additional net shares (the number of which is not yet determinable) remaining after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs, in each case, at prices determined in accordance with the terms of the Napolitano Plan, all between November 30, 2026 and December 3, 2027. The Napolitano Plan includes a representation from Ms. Napolitano to the broker administering the plan that she was not in possession of any material nonpublic information regarding us or the securities subject to the Napolitano Plan at the time that she entered into the Napolitano Plan. She made a similar representation to us in connection with the adoption of the Napolitano Plan under our insider trading policy. The representation was made as of August 31, 2026, and speaks only as of that date. In making the representation, Ms. Napolitano did not provide assurance with respect to any material nonpublic information of which she was unaware, or with respect to any material nonpublic information acquired by her or us after the date of the representation. Once executed, transactions under the Napolitano Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules and regulations. Except as may be required by law, we do not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Napolitano or our other officers or directors, or their affiliated entities.
Christiane Ohlgart
Chief Financial Officer
Adopted 10b5-1 plan Jun 10, 2026 up to 115 Sep 15, 2027 10-Q Jul 30, 2026
What the company wrote
On June 10, 2026, Christiane Ohlgart, our Chief Financial Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ohlgart Plan”) during an open trading window in accordance with our insider trading policy. The Ohlgart Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ohlgart Plan provides for the potential sale by Mrs. Ohlgart of up to 115 shares of our common stock, plus a number of additional net shares (which is not yet determinable) remaining after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs and PSUs, in each case, at prices determined in accordance with the terms of the Ohlgart Plan, all between September 9, 2026 and September 15, 2027.
John Whittle
Chief Operating Officer
Adopted 10b5-1 plan Jun 5, 2026 up to 56,700 Sep 30, 2027 10-Q Jul 30, 2026
What the company wrote
On June 5, 2026, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 56,700 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at prices at or above a minimum price specified in the Whittle Plan, all between September 4, 2026 and September 30, 2027.
Michael Xie
Chief Technology Officer and one of our directors
Adopted 10b5-1 plan Mar 4, 2026 up to 466,239 Nov 30, 2027 10-Q May 8, 2026
What the company wrote
On March 4, 2026, Michael Xie, our Chief Technology Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Michael Xie Plan”) during an open trading window in accordance with our insider trading policy. The Michael Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Michael Xie Plan provides for the potential sale by Mr. Michael Xie of up to (a) 466,239 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 3, 2026 and November 30, 2027.
Ken Xie
Chief Executive Officer and one of our directors
Adopted 10b5-1 plan Mar 3, 2026 up to 1,164,981 Nov 30, 2027 10-Q May 8, 2026
What the company wrote
On March 3, 2026, Ken Xie, our Chief Executive Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ken Xie Plan”) during an open trading window in accordance with our insider trading policy. The Ken Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ken Xie Plan provides for the potential sale by Mr. Ken Xie of up to (a) 1,164,981 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 2, 2026 and November 30, 2027.
John Whittle
Chief Operating Officer
Adopted 10b5-1 plan Feb 19, 2026 up to 146,015 May 28, 2027 10-Q May 8, 2026
What the company wrote
On February 19, 2026, John Whittle, our Chief Operating Officer, modified an existing trading plan, which was originally adopted on March 3, 2025 in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The modified Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The modified Whittle Plan provides for the potential sale by Mr. Whittle of up to 146,015 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at the market price, between May 21, 2026 and May 28, 2027.
Keith Jensen
Chief Financial Officer
Ended 10b5-1 plan May 15, 2025 not stated – 10-Q Aug 8, 2025
What the company wrote
As previously reported, our former Chief Financial Officer, Keith Jensen, retired on May 15, 2025. In connection with Mr. Jensen’s retirement, his pre-arranged written stock sale plan for the sale of shares of our common stock adopted on March 6, 2024 was terminated.
Margrit Christiane Ohlgart
Chief Accounting Officer
Adopted 10b5-1 plan Mar 7, 2025 not stated Sep 5, 2026 10-Q May 8, 2025
What the company wrote
On March 7, 2025, Margrit Christiane Ohlgart, our Chief Accounting Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ohlgart Plan”) during an open trading window in accordance with our insider trading policy. The Ohlgart Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ohlgart Plan provides for the potential sale by Mrs. Ohlgart of net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 6, 2025 and September 5, 2026.
John Whittle
Chief Operating Officer
Adopted 10b5-1 plan Mar 3, 2025 up to 146,015 Jul 31, 2026 10-Q May 8, 2025
What the company wrote
On March 3, 2025, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 146,015 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at the market price, between June 2, 2025 and July 31, 2026.
Michael Xie
Chief Technology Officer and one of our directors,
Adopted 10b5-1 plan Dec 10, 2024 up to 624,285 512 days 10-K Feb 21, 2025
What the company wrote
On December 10, 2024, Michael Xie, our Chief Technology Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Michael Xie Plan”) during an open trading window in accordance with our insider trading policy. The Michael Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Michael Xie Plan provides for the potential sale by Mr. Xie of up to (a) 624,285 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between March 11, 2025 and May 6, 2026.
Ken Xie
Chief Executive Officer and one of our directors
Adopted 10b5-1 plan Dec 9, 2024 up to 734,880 513 days 10-K Feb 21, 2025
What the company wrote
On December 9, 2024, Ken Xie, our Chief Executive Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ken Xie Plan”) during an open trading window in accordance with our insider trading policy. The Ken Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ken Xie Plan provides for the potential sale by Mr. Xie of up to (a) 734,880 shares of our common stock, issued upon the vesting and settlement of RSUs and PSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between March 10, 2025 and May 6, 2026.
Kenneth A. Goldman
directors
Adopted 10b5-1 plan Dec 9, 2024 up to 3,000 456 days 10-K Feb 21, 2025
What the company wrote
On December 9, 2024, Kenneth A. Goldman, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Goldman Plan”) during an open trading window in accordance with our insider trading policy. The Goldman Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Goldman Plan provides for the potential sale by Mr. Goldman of up to 3,000 shares of our common stock, issued upon the exercise of vested options to purchase shares of our common stock, at the market price, so long as the market price is equal to or greater than $95.00 per share, between March 10, 2025 and March 10, 2026.
William H. Neukom
directors
Adopted 10b5-1 plan Dec 9, 2024 not stated 452 days 10-K Feb 21, 2025
What the company wrote
On December 9, 2024, William H. Neukom, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the purchase of shares of our common stock (the “Neukom Plan”) during an open trading window in accordance with our insider trading policy. The Neukom Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Neukom Plan provides for the potential purchase by Mr. Neukom of up to $35,000 worth of shares of our common stock per at the market price, on five dates between March 6, 2025 and March 6, 2026, as specified in the Neukom Plan.
John Whittle
Chief Operating Officer
Adopted 10b5-1 plan May 22, 2024 up to 141,820 548 days 10-Q Aug 8, 2024
What the company wrote
On May 22, 2024, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 141,820 shares of our common stock, issued upon the exercise of vested options to purchase shares of our common stock, at the market price, between August 21, 2024 and February 20, 2026. The Whittle Plan includes a representation from Mr. Whittle to the broker administering the plan that he was not in possession of any material nonpublic information regarding us or the securities subject to the Whittle Plan at the time that he entered into the Whittle Plan. He made a similar representation to us in connection with the adoption of the Whittle Plan under our insider trading policy. The representation was made as of May 22, 2024 and speaks only as of that date. In making the representation, Mr. Whittle did not provide assurance with respect to any material nonpublic information of which he was unaware, or with respect to any material nonpublic information acquired by him or us after the date of the representation. Once executed, transactions under the Whittle Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules and regulations. Except as may be required by law, we do not undertake any obligation to update or report any modification, termination or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Whittle or our other officers or directors or their affiliated entities.
Keith Jensen
Chief Financial Officer
Adopted 10b5-1 plan Mar 6, 2024 up to 163,170 367 days 10-Q May 6, 2024
Judith Sim
director
Adopted 10b5-1 plan Dec 6, 2023 up to 20,637 367 days 10-K Feb 26, 2024
Patrice Perche
Chief Revenue Officer and Executive Vice President of Support
Adopted 10b5-1 plan Nov 13, 2023 up to 141,981 454 days 10-K Feb 26, 2024
Ken Xie
officers and director
Adopted plan – up to 150,000 434 days 10-Q Nov 7, 2023
Michael Xie
officers and director
Adopted plan – up to 100,000 434 days 10-Q Nov 7, 2023
Michael Xie and Ken Xie
Adopted plan – up to 50,000 434 days 10-Q Nov 7, 2023
Show the other 12 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.

Form 144

Notices of planned sales

Form 144 XML, SEC
FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Nov 2, 2026 KEN XIE
Director, Officer
161,483 $22.0M Exercise of Stock Options; Restricted Stock Units adopted Mar 3, 2026 161,483 shares from Nov 2, 2026
Nov 2, 2026 MICHAEL XIE
Director, Officer
3,121 $425K Restricted Stock Units adopted Mar 4, 2026 3,121 shares from Nov 2, 2026
Sep 24, 2026 Margrit Christiane Ohlgart
Officer
48 $9K Restricted Stock Units adopted Jun 10, 2026 48 shares from Sep 24, 2026
Sep 14, 2026 JOHN WHITTLE
Officer
56,700 $8.8M Exercise of Stock Options adopted Jun 5, 2026 56,700 shares from Sep 14, 2026
Aug 4, 2026 Margrit Christiane Ohlgart
Officer
387 $63K Restricted Stock Units adopted Mar 7, 2025 387 shares from Aug 4, 2026
Aug 3, 2026 KEN QING XIE
Director, Officer
161,482 $26.2M Exercise of Stock Options; Restricted Stock Units adopted Mar 3, 2026 161,482 shares from Aug 3, 2026
Aug 3, 2026 MICHAEL XIE
Director, Officer
3,121 $505K Restricted Stock Units adopted Mar 4, 2026 3,121 shares from Aug 3, 2026
Jun 3, 2026 MICHAEL XIE
Director, Officer
3,907 $582K Restricted Stock Units adopted Mar 4, 2026 3,907 shares from Jun 3, 2026
Jun 2, 2026 KEN QING XIE
Director, Officer
160,632 $23.6M Exercise of Stock Options; Restricted Stock Units adopted Mar 3, 2026 160,632 shares from Jun 2, 2026
May 21, 2026 JOHN WHITTLE
Officer
146,015 $19.0M Exercise of Stock Options adopted Feb 19, 2026 146,015 shares from May 21, 2026
May 20, 2026 Margrit Christiane Ohlgart
Officer
238 $30K RSU/PSU adopted Mar 7, 2025 238 shares from May 20, 2026
May 14, 2026 Margrit Christiane Ohlgart
Officer
756 $89K RSU/PSU adopted Mar 7, 2025 994 shares from May 14, 2026
May 11, 2026 MARGRIT CHRISTIANE OHLGART
Officer
238 $27K RSU/PSU adopted Mar 7, 2025 1,232 shares from May 11, 2026
May 7, 2026 MARGRIT CHRISTIANE OHLGART
Officer
756 $68K RSU/PSU adopted Mar 7, 2025 1,988 shares from May 7, 2026
May 5, 2026 MARGRIT CHRISTIANE OHLGART
Officer
596 $53K Restricted Stock Units and Performance Stock Units adopted Mar 7, 2025 2,584 shares from May 5, 2026
May 4, 2026 KEN QING XIE
Director, Officer
5,355 $462K Restricted Stock Units adopted Dec 9, 2024 165,987 shares from May 4, 2026
May 4, 2026 MICHAEL XIE
Director, Officer
2,478 $214K Restricted Stock Units adopted Dec 10, 2024 6,385 shares from May 4, 2026
Feb 3, 2026 MARGRIT CHRISTIANE OHLGART
Officer
507 $41K Restricted Stock Units and Performance Stock Units adopted Mar 7, 2025 none found
Feb 2, 2026 KEN QING XIE
Director, Officer
175,737 $14.3M Exercise of Stock Options; Performance Stock Units; Restricted Stock Units adopted Dec 9, 2024 none found
Feb 2, 2026 MICHAEL XIE
Director, Officer
343,106 $27.9M Exercise of Stock Options; Performance Stock Units; Restricted Stock Units adopted Dec 10, 2024 none found
Nov 4, 2025 MARGRIT CHRISTIANE OHLGART
Officer
110 $10K Restricted Stock Units adopted Mar 7, 2025 none found
Nov 3, 2025 MICHAEL XIE
Director, Officer
3,546 $306K Restricted Stock Units adopted Dec 10, 2024 none found
Nov 3, 2025 KEN QING XIE
Director, Officer
158,485 $13.7M Exercise of Stock Options; Restricted Stock Units adopted Dec 9, 2024 none found
Show the other 15 notices

From the Form 144 XML filed with the SEC, since Nov 3, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →